174 related articles for article (PubMed ID: 28481918)
21. Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.
Wang W; Oh S; Koester M; Abramowicz S; Wang N; Tall AR; Welch CL
Circ Cardiovasc Genet; 2016 Jun; 9(3):213-22. PubMed ID: 27098250
[TBL] [Abstract][Full Text] [Related]
22. Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.
Duesing K; Fatemifar G; Charpentier G; Marre M; Tichet J; Hercberg S; Balkau B; Froguel P; Gibson F
Diabetologia; 2008 May; 51(5):821-6. PubMed ID: 18368387
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.
Zhang W; Kuang P; Liu T
Ann Med; 2019 Feb; 51(1):28-40. PubMed ID: 30592434
[TBL] [Abstract][Full Text] [Related]
24. CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia.
Jang W; Park J; Kwon A; Choi H; Kim J; Lee GD; Han E; Jekarl DW; Chae H; Han K; Yoon JH; Lee S; Chung NG; Cho B; Kim M; Kim Y
Exp Mol Med; 2019 Jan; 51(1):1-15. PubMed ID: 30635552
[TBL] [Abstract][Full Text] [Related]
25. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
Vijayakrishnan J; Henrion M; Moorman AV; Fiege B; Kumar R; da Silva Filho MI; Holroyd A; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Bartram CR; Schrappe M; Greaves M; Hemminki K; Harrison CJ; Stanulla M; Houlston RS
Sci Rep; 2015 Oct; 5():15065. PubMed ID: 26463672
[TBL] [Abstract][Full Text] [Related]
26. Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.
Genescà E; Lazarenkov A; Morgades M; Berbis G; Ruíz-Xivillé N; Gómez-Marzo P; Ribera J; Juncà J; González-Pérez A; Mercadal S; Guardia R; Artola MT; Moreno MJ; Martínez-López J; Zamora L; Barba P; Gil C; Tormo M; Cladera A; Novo A; Pratcorona M; Nomdedeu J; González-Campos J; Almeida M; Cervera J; Montesinos P; Batlle M; Vives S; Esteve J; Feliu E; Solé F; Orfao A; Ribera JM
J Hematol Oncol; 2018 Jul; 11(1):96. PubMed ID: 30041662
[TBL] [Abstract][Full Text] [Related]
27. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
Sattarzadeh Bardsiri M; Zehtab S; Karami N; Farsinejad A; Ehsan M; Fatemi A
BMC Med Genomics; 2022 Aug; 15(1):171. PubMed ID: 35932035
[TBL] [Abstract][Full Text] [Related]
28. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.
Boldrin E; Gaffo E; Niedermayer A; Boer JM; Zimmermann M; Weichenhan D; Claus R; Münch V; Sun Q; Enzenmüller S; Seyfried F; Demir S; Zinngrebe J; Cario G; Schrappe M; Den Boer ML; Plass C; Debatin KM; Te Kronnie G; Bortoluzzi S; Meyer LH
Blood; 2021 Nov; 138(20):1953-1965. PubMed ID: 34098582
[TBL] [Abstract][Full Text] [Related]
30. Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.
Thakur N; Kupani M; Mannan R; Pruthi A; Mehrotra S
BMC Med Genomics; 2021 Jan; 14(1):1. PubMed ID: 33397358
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men.
Akinyemi R; Arnett DK; Tiwari HK; Ovbiagele B; Sarfo F; Srinivasasainagendra V; Irvin MR; Adeoye A; Perry RT; Akpalu A; Jenkins C; Owolabi L; Obiako R; Wahab K; Sanya E; Komolafe M; Fawale M; Adebayo P; Osaigbovo G; Sunmonu T; Olowoyo P; Chukwuonye I; Obiabo Y; Akpa O; Melikam S; Saulson R; Kalaria R; Ogunniyi A; Owolabi M;
J Neurol Sci; 2017 Aug; 379():229-235. PubMed ID: 28716248
[TBL] [Abstract][Full Text] [Related]
32. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
33. The Yin and Yang-Like Clinical Implications of the
González-Gil C; Ribera J; Ribera JM; Genescà E
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435487
[TBL] [Abstract][Full Text] [Related]
34. Association study of the miRNA-binding site polymorphisms of CDKN2A/B genes with gestational diabetes mellitus susceptibility.
Wang X; Li W; Ma L; Gao J; Liu J; Ping F; Nie M
Acta Diabetol; 2015 Oct; 52(5):951-8. PubMed ID: 25990668
[TBL] [Abstract][Full Text] [Related]
35. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
[TBL] [Abstract][Full Text] [Related]
36. Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood.
Novara F; Beri S; Bernardo ME; Bellazzi R; Malovini A; Ciccone R; Cometa AM; Locatelli F; Giorda R; Zuffardi O
Hum Genet; 2009 Oct; 126(4):511-20. PubMed ID: 19484265
[TBL] [Abstract][Full Text] [Related]
37. Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.
Ribera J; Zamora L; Morgades M; Mallo M; Solanes N; Batlle M; Vives S; Granada I; Juncà J; Malinverni R; Genescà E; Guàrdia R; Mercadal S; Escoda L; Martinez-Lopez J; Tormo M; Esteve J; Pratcorona M; Martinez-Losada C; Solé F; Feliu E; Ribera JM;
Genes Chromosomes Cancer; 2017 Nov; 56(11):810-820. PubMed ID: 28758283
[TBL] [Abstract][Full Text] [Related]
38. A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology.
Hungate EA; Vora SR; Gamazon ER; Moriyama T; Best T; Hulur I; Lee Y; Evans TJ; Ellinghaus E; Stanulla M; Rudant J; Orsi L; Clavel J; Milne E; Scott RJ; Pui CH; Cox NJ; Loh ML; Yang JJ; Skol AD; Onel K
Nat Commun; 2016 Feb; 7():10635. PubMed ID: 26868379
[TBL] [Abstract][Full Text] [Related]
39. Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia.
Healy J; Bélanger H; Beaulieu P; Larivière M; Labuda D; Sinnett D
Blood; 2007 Jan; 109(2):683-92. PubMed ID: 17008550
[TBL] [Abstract][Full Text] [Related]
40. Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population.
Plengvidhya N; Chanprasert C; Chongjaroen N; Yenchitsomanus PT; Homsanit M; Tangjittipokin W
BMC Med Genet; 2018 Jun; 19(1):93. PubMed ID: 29871606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
